Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06938854

Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries

Prospective, Multi-center, Single-arm Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Shockwave Medical, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Disrupt PAD Japan is a prospective, multi-center, single-arm study of SWM-831 to treat moderate and severely calcified femoropopliteal arteries, prior to DCB or stenting.

Detailed description

Up to 60 subjects at up to 10 sites in Japan will be enrolled in the femoropopliteal clinical study with moderate and severely calcified femoropopliteal artery disease presenting with Rutherford Category 2 - 5 of the target limb. Two additional cohorts \[Iliac and BTK (Below-the-Knee)\] will enroll a minimum of 10 and a maximum of 15 subjects each with moderate and severely calcified iliac disease with a Rutherford Category (RC) 2 - 5 and a minimum of 10 and a maximum of 15 subjects with moderate and severely calcified BTK lesions with a Rutherford Category (RC) 2 - 5 will be enrolled and followed through 12 months. The estimated study duration for these cohorts is approximately 24 months. Study subjects will be followed through discharge, 30 days, 6, and 12 months.

Conditions

Interventions

TypeNameDescription
DEVICEPeripheral Intravascular Lithotripsy (IVL)For the Disrupt PAD Japan study, the Shockwave Medical Peripheral IVL System (SWM-831) is intended for lithotripsy enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the femoropopliteal arteries.

Timeline

Start date
2025-03-10
Primary completion
2027-01-31
Completion
2028-03-01
First posted
2025-04-22
Last updated
2025-12-11

Locations

10 sites across 1 country: Japan

Regulatory

Source: ClinicalTrials.gov record NCT06938854. Inclusion in this directory is not an endorsement.

Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries (NCT06938854) · Clinical Trials Directory